Skip to search formSkip to main contentSkip to account menu

Recombinant Interleukin-17

Known as: CTLA-8 (Therapeutic), IL-17, Interleukin-17 
A recombinant agent, which is chemically identical or similar to the endogenous cytokine interleukin-17 (IL-17). IL-17 is produced by cytotoxic T… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract not available. This study was supported by Amgen/AstraZeneca. This poster was sponsored b y LEO Pharma. 
2017
2017
Corticosteroid resistance and severe airflow obstruction have been proved to participate in the neutrophilic inflammation of… 
2017
2017
through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and… 
2017
2017
Preeclampsia is a pregnancy pathological condition characterized by increased blood tekananan and the occurrence of Uriah… 
2016
2016
Objective To observe serum levels of interleukin-17 (IL-17) and tumor necrosis factor-α (TNF-α) in dermatomyositis (DM) patients… 
2014
2014
Background and purpose: Using allogeneic and xenogeneic mesenchymal stem cells (MSCs) has had some successful results in the… 
2013
2013
According to the World Health Organization, more than two billion people, equivalent to one third of the world’s population are… 
2010
2010
[Objective] To explore the changes of interleukin-17 and interleukin-18 levels in peripheral blood of patients with systemic… 
Review
2004
Review
2004
IL-17 and its receptor are founding members of an emerging family of cytokines and receptors with many unique characteristics. IL…